From: Triple negative breast cancer in North of Morocco: clinicopathologic and prognostic features
Variable | Frequency |
---|---|
TNBC | 17.6 % |
Median age at diagnosis | 46 ans |
Ethnicity | Â |
Arab | 69.4 % |
Amazigh | 26.6 % |
Sub-Saharan | 2 % |
European | 2 % |
Menopause | Â |
Yes | 36.4 % |
No | 63.6 % |
Breast cancer family history | Â |
Present | 24.4 % |
Absent | 75.6 % |
Tumor size | Â |
T1 | 10.2 % |
T2 | 73.5 % |
T3 | 12.2 % |
T4 | 4.1 % |
Histological type | Â |
Invasive ductalcarcinoma | 91.8 % |
Invasive lobularcarcinoma | 8.2 % |
SBR grading | Â |
I | 4.3 % |
II | 55.3 % |
III | 40.4 % |
Lymphovascular invasion | Â |
Present | 36.6 % |
Absent | 63.4 % |
Lymph node status | Â |
N0 | 61.1 % |
N1 | 25 % |
N2 | 5.6 % |
N3 | 8.3 % |
Metastasisat initial diagnosis | Â |
M0 | 87.8 % |
M1 | 12.2 % |
TNM stage | Â |
I | 12.2 % |
II | 40.8 % |
III | 34.7 % |
IV | 12.2 % |
Distant metastasis | Â |
M0 | 86 % |
M1 | 14 % |
Recurrence sites | Â |
Local | 6.1 % |
Bone | 4.1 % |
Liver | 10.2 % |
Lung | 8.2 % |
Brain | 2.1 % |